TriSalus Life Sciences (TLSI) S-1/A IPO registration (amended)

Exhibit 23.2

	KPMG LLP Suite 800 1225 17th Street Denver, CO 80202-5598

Consent of Independent Registered Public Accounting Firm

We consent to the use of our report dated April 21, 2023, except for Note 2a, as to which the date is December 14, 2023, with respect to the consolidated financial statements of TriSalus Life Sciences, Inc, included herein, and to the reference to our firm under the heading “Experts” in the prospectus.

Denver, Colorado

December 14, 2023

KPMG LLP, a Delaware limited liability partnership and a member firm of
the KPMG global organization of independent member firms affiliated
withKPMG International Limited, a private English company limited by guarantee.